General Archive

Home » Archives for Natalya Butterworth » Page 4
  • Physiotherapist assisting a patient with MND.
    News releases

    £1 million awarded to develop cutting-edge therapies for motor neuron disease

    London, 24 January 2023: Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5 Doddie…

    Read more

  • Doctor holding a syringe with a single bottle vial of Covid-19
    News releases

    LifeArc portfolio company RQ Bio’s antibody enters clinical trials

    The first of RQ Bio’s discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients has entered clinical trials.

    Read more

  • Dr David Powell, Chief Scientific Officer at LifeArc
    Articles

    Alzheimer’s drug lecanemab approved by US regulator

    LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the…

    Read more

  • Dave Powell, LifeArc's Chief Business Officer
    News releases

    Evolving our science to solve complex healthcare challenges

    Dave Powell on why LifeArc is evolving the way we do our science – and the difference we hope it…

    Read more

  • Articles

    2022 wrapped – our highlights from a pivotal year

    We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.

    Read more

  • Woman uses a nebulizer at home.
    News releases

    LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis

    Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.

    Read more

  • Motor neurons grown from stem cells using complex developmental biology techniques (differentiated these cells from induced pluripotent stem cells/iPSCs (not embryonic stem cells)). In blue is the centre of each cell (the nucleus), and in red is the main structural component of each cell (the cytoskeleton).
    Articles

    MND Collaborative Partnership cautiously welcomes new Government funding

    We cautiously welcome the Government’s announcement on how their £50m commitment into MND research will be spent.

    Read more

  • Articles

    Repurposed flu medicine could help under 60s recover faster from COVID-19

    Results of an international repurposing study show favipiravir could help with COVID-19.

    Read more

  • Person using nebulizer and inhaler for the treatment
    News releases

    LifeArc announces £10m funding call for new chronic respiratory infection therapies

    First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge

    Read more

  • Microscopic view of lung tissue with congestion as shown by the red blood cells in the walls of the alveoli. Pneumonia.
    News releases

    £100m programme to transform care for people living with chronic lung conditions

    More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic…

    Read more

  • Melanie Lee, LifeArc CEO
    News releases

    LifeArc responds to the Government’s renewed pledge to increase R&D funding

    LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&D funding in today’s Autumn statement:…

    Read more

  • Photo of older woman with her carer
    Articles

    LifeArc plays key role in discovery of new Alzheimer’s treatment

    LifeArc played an important part in the discovery of lecanemab, an experimental drug that has shown some benefits for people…

    Read more